Nicole Germino
Stock Analyst at Truist Securities
(3.62)
# 819
Out of 5,124 analysts
23
Total ratings
65%
Success rate
34.93%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Nicole Germino
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSM Insmed | Maintains: Buy | $126 → $139 | $175.07 | -20.60% | 10 | Aug 14, 2025 | |
| CATX Perspective Therapeutics | Maintains: Buy | $10 → $8 | $2.81 | +184.70% | 3 | May 14, 2025 | |
| SGMO Sangamo Therapeutics | Maintains: Buy | $7 → $5 | $0.44 | +1,025.87% | 5 | Jan 23, 2025 | |
| ASMB Assembly Biosciences | Downgrades: Hold | $132 → $24 | $30.58 | -21.52% | 3 | Oct 24, 2022 | |
| FBRX Forte Biosciences | Downgrades: Hold | n/a | $23.46 | - | 2 | Sep 3, 2021 |
Insmed
Aug 14, 2025
Maintains: Buy
Price Target: $126 → $139
Current: $175.07
Upside: -20.60%
Perspective Therapeutics
May 14, 2025
Maintains: Buy
Price Target: $10 → $8
Current: $2.81
Upside: +184.70%
Sangamo Therapeutics
Jan 23, 2025
Maintains: Buy
Price Target: $7 → $5
Current: $0.44
Upside: +1,025.87%
Assembly Biosciences
Oct 24, 2022
Downgrades: Hold
Price Target: $132 → $24
Current: $30.58
Upside: -21.52%
Forte Biosciences
Sep 3, 2021
Downgrades: Hold
Price Target: n/a
Current: $23.46
Upside: -